Your Product Has Studies. But Do They Support Your Claims?

Having studies is not enough

Imagine a company selling a supplement for a particular health benefit. The ingredient has been researched. There are published studies. The supplier provides scientific references. Everything appears well supported.

So the company builds its marketing around the research.

Then someone looks more closely.

The studies used a different dose. Or a different formulation. Perhaps the participants were very different from the customers being targeted. Or the study measured one outcome while the marketing promises another.

The studies are real. The problem is that they may not prove what the company is saying about its product.

Where the gap appears

Suppose research shows that an ingredient improved a particular outcome when people consumed 1,000 mg per day. Your product contains 250 mg. Can you use that study to support the same expected benefit?

Or perhaps a study found an improvement in adults with a specific condition, but your advertising suggests that healthy adults can expect the same result.

Or research supports one ingredient individually, while your marketing attributes the same result to a finished multi-ingredient formula that has never been studied.

These differences may look small during product development or marketing. They can become very important when the claim is challenged.

When Product Claims Become a Business Problem

Health-related advertising is expected to have appropriate scientific support, and the evidence needs to be relevant to the product and the claim being made.

Regulators are not the only people who may examine it. Retailers can question claims before carrying a product. Investors may examine the evidence during due diligence. Attorneys can scrutinize substantiation in litigation. Competitors can challenge advertising.

A claim that helped sell the product can therefore become a liability if the evidence behind it cannot withstand closer examination.

More studies do not necessarily solve the problem

One common response is to collect more references. But fifty studies that do not match the product or claim do not necessarily create a stronger position than a few highly relevant studies.

A laboratory study showing that an ingredient affects a biological pathway may help explain how something could work. It does not automatically demonstrate that consumers taking the finished product will experience the advertised result.

Similarly, a study of an ingredient does not automatically establish that every product containing that ingredient will perform the same way.

This is where apparently strong scientific support can become much weaker when examined closely.

The problem is cheaper to find before the claim goes public

Companies often examine substantiation after the marketing language has already been developed. That reverses the order of the decision.

If the evidence supports a narrower outcome than the marketing team wants to communicate, discovering that before packaging, advertising and launch leaves room to change the claim, strengthen the evidence or reconsider the product strategy.

Discovering the problem after scrutiny begins leaves fewer options and potentially much greater cost.

The purpose of evaluating the evidence early is therefore not simply to accumulate scientific references. It is to understand what the company can confidently say, what it cannot say, and where an evidence gap could become a business problem.